GIA
ETNB

Gladstone Institutional Advisory’s 89bio ETNB Stock Holding History

Gladstone Institutional Advisory’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,000
Closed -$154K – 675
2023
Q3 		$154K Hold
10,000
– – 0.01% 586
2023
Q2 		$190K Hold
10,000
– – 0.01% 598
2023
Q1 		$152K Hold
10,000
– – 0.01% 623
2022
Q4 		$127K Buy
+10,000
New +$90K 0.01% 616

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Gladstone Institutional Advisory's ETNB Position: Q4 2023 in Review

Gladstone Institutional Advisory sold out of 89bio (ETNB) in Q4 2023, closing a stake of 10,000 shares — an estimated $154K sold.

Gladstone Institutional Advisory first reported a position in ETNB in Q4 2022 and held it in 4 quarters. The position peaked at $190K in Q2 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

  • Gladstone Institutional Advisory reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 10,000 89bio shares in Q4 2023, an estimated $154K.
  • Gladstone Institutional Advisory first reported a position in 89bio in Q4 2022 and held it in 4 quarters.
  • Gladstone Institutional Advisory's 89bio position peaked at $190K in Q2 2023.
  • 153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on Gladstone Institutional Advisory's 13F filing for Q4 2023, filed 9 Feb 2024.